Navigation überspringen
article cover
Data-driven PAT systems will be able to provide valuable insight into pharmaceutical manufacturing processes and... - source of the figure: the author

How can Process Analytical Technology help shape the future of pharmaceutical manufacturing?

Industrial internet of things and data analytics are the foundation of futureproof total quality management

The latest innovations in sensor and network technologies are enabling pharmaceutical manufacturers to collect unprecedented volumes of data generated in their laboratories, processing units and factory floors. Combined with recent advances in Big Data analytics and mining, these can be used to support automated operations and gain unique actionable insight to help optimise drug production activities. Furthermore, these solutions can drive continuous improvement strategies that can grow a business’s competitive edge in an ever-evolving, highly demanding market.

These opportunities can also be used to develop an enhanced Process Analytical Technology (PAT) framework, supporting the creation of a more interconnected, comprehensive and smart manufacturing system. For example, it is possible to create an industrial internet of things (IIoT)-based environment that utilises advanced analytics and simulations within a plant as well as across an entire enterprise. Ultimately, businesses can implement successful total quality management practices that lead to increasingly flexible and intelligent, quality-driven facilities that operate in a highly efficient and effective manner.

This article looks at the most significant opportunities for PAT in the digital era and how they can benefit the pharmaceutical sector. It discusses how to select key solutions to implement a futureproof PAT framework that can maximise the benefits of smart manufacturing.

https://www.ecv.de/beitrag/pharmind/How_can_Process_Analytical_Technology_help_shape_the_future_of_pharmaceutical_manufacturing

PHARMA-IMPACT schreibt über Bringt Entscheider weiter!

Die beiden Zeitschriften pharmind und Tech4Pharma (vormals TechnoPharm) publizieren exklusive Fachbeiträge für die international agierende Pharmaindustrie. Die Artikel werden von einem Redaktionsbeirat im Review-Verfahren nach qualitativen Maßstäben geprüft und ausgewählt. Daraus entsteht ein Themenspektrum, so einzigartig und vielseitig wie die Branche selbst. Unter der Marke Pharma-Impact bündelt der ECV Editio Cantor Verlag die unterschiedlichen inhaltlichen Orientierungen der Titel (pharmazeutisch / technisch) zu einem attraktiven Gesamtangebot für alle Entscheider, Experten und Multiplikatoren aus der Pharma- und Zulieferindustrie.

Artikelsammlung ansehen